Zhongshan, China · Founded 2017 · Privately Held (backing)
Developer of antibody drugs intended to improve the quality of life for cancer patients. Dartsbio Pharmaceuticals is based in Zhongshan, China and was founded in 2017. Its last reported valuation was $15.7 million in May 2020. It has raised $36 million.
Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$36.0M
Last round
—
Cap table — not yet on record
Dartsbio Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dartsbio Pharmaceuticals with a free account
·The complete investor list: 11 names
·Watch Dartsbio Pharmaceuticals: the Monday email on marks, rounds and moves
